Financial Projections - The projected net profit for 2025 is estimated to be between -30 million to -26 million CNY, representing a decline of 25.30% to 8.59% compared to the previous year's loss of 23.94 million CNY[5]. - The overall fixed costs of the company remain high, contributing to the anticipated losses in the 2025 fiscal year[7]. - The financial data presented is preliminary and has not been audited, with investors advised to consider the associated risks[8]. Business Performance - The company's existing business segments, including micro-ecological preparations, feed, enzyme preparations, and veterinary medicine, are expected to maintain revenue levels similar to 2024, but the gross profit margin has decreased significantly due to a drop in the sales proportion of high-margin mixed feed additives[7]. - The pig farming business has not achieved profitability in 2025 due to significant price fluctuations in the pig market during the fourth quarter, impacting overall financial performance[7]. - The company faces increased competition in the feed additives and veterinary medicine markets, leading to pressure on its related business operations[6].
大禹生物(920970) - 2025 Q4 - 年度业绩预告